Increased in vitro differentiation of fibrocytes from keloid patients is inhibited by serum amyloid P
Increased in vitro differentiation of fibrocytes from keloid patients is inhibited by serum amyloid P
复制标题
DOI:
10.1111/j.1524-475x.2012.00782.x
复制
发表时间:
2012-05-01
影响因子:
2.9
通讯作者:
Olutoye, Oluyinka O.
中科院分区:
文献类型:
--
作者:
Naylor, Michelle C.;Lazar, David A.;Olutoye, Oluyinka O.
Keloid scarring is a form of fibroproliferative dermal wound healing characterized by growth beyond the confines of the original wound. Fibrocytes, derived from peripheral blood mononuclear cells and inhibited by serum amyloid P (SAP), have been linked to other fibroproliferative diseases. We hypothesized that peripheral blood mononuclear cells of keloid formers have a higher propensity to differentiate into fibrocytes and are more resistant to the effects of SAP. To test this hypothesis, plasma was isolated from peripheral blood samples of keloid (n?=?10) and age/sex/race-matched control (n?=?10) subjects, and SAP levels were measured by enzyme-linked immunosorbent assay. Equal numbers of peripheral blood mononuclear cells were also isolated from these samples and fibrocytes cultured in serum-free media with increasing concentrations of SAP. No difference in plasma SAP levels was found between keloid and control subjects. In the absence of SAP, keloid patients (n?=?7) had almost 20 times more fibrocytes than controls (n?=?7) in culture (median: 1,087 cells vs. 60 cells; p?